hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.

Item

http://www.wikidata.org/entity/Q51612185

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.

@en

hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.

@nl

type

Item

label

hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.

@en

hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.

@nl

prefLabel

hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.

@en

hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.

@nl

P1476

hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.

@en

P2093

Andrea Wagner

http://www.w3.org/2001/XMLSchema#string

Benjamin Brokinkel

http://www.w3.org/2001/XMLSchema#string

Gina Fürtjes

http://www.w3.org/2001/XMLSchema#string

Katharina Heß

http://www.w3.org/2001/XMLSchema#string

Michaela Köchling

http://www.w3.org/2001/XMLSchema#string

Susanne Peetz-Dienhart

http://www.w3.org/2001/XMLSchema#string

Volker Senner

http://www.w3.org/2001/XMLSchema#string

Walter Stummer

http://www.w3.org/2001/XMLSchema#string

Werner Paulus

http://www.w3.org/2001/XMLSchema#string

P2860

ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis.

ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples samples.

Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma.

5-aza-2'-deoxycytidine-mediated c-myc Down-regulation triggers telomere-dependent senescence by regulating human telomerase reverse transcriptase in chronic myeloid leukemia.

Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia.

Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma.

Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.

The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression.

Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

P2888

s11060-016-2226-6

P304

79-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-016-2226-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P50

Martin Hasselblatt

P577

2016-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27465278

http://www.w3.org/2001/XMLSchema#string